🇮🇳IN
Sign In
VA

VAISHALI

NSE

Vaishali Pharma Limited

₹6.87

-0.36(-4.98%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

VAISHALI financial summary

For Mar 2026, Vaishali Pharma Limited reported revenue of ₹109 crore, which grew 10.1% from the previous year. Net profit was ₹4 crore, which grew 300.0% year on year, on an operating margin of 4%. Earnings per share came in at ₹0.31. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹109 crore
Net profit₹4 crore
Operating margin4%
EPS₹0.31

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer